Hoffmann, how are they going to approve the Flaskworks system's efficacy without having documenting its equivalence (and hopefully its superiority to the manual system) by using it to treat a number of GBM patients?
I would not be surprised if Advent had been treating a number of patients that way and most likely those patients would have received the treatment free of charge.